Clinical performance of real-time nanopore metagenomic sequencing for rapid identification of bacterial pathogens in cerebrospinal fluid: a pilot study

Abstract This study aimed to evaluate the usefulness of amplicon-based real-time metagenomic sequencing applied to cerebrospinal fluid (CSF) for identifying the causative agents of bacterial meningitis. We conducted a 16S rRNA amplicon sequencing using a nanopore-based platform, alongside routine po...

Full description

Saved in:
Bibliographic Details
Main Authors: Yoon Hyun Sung, Yong Kuk Ju, Hak Jun Lee, Seung Min Park, Jin Woong Suh, Jeong Yeon Kim, Jang Wook Sohn, Young Kyung Yoon
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-87858-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832571749046157312
author Yoon Hyun Sung
Yong Kuk Ju
Hak Jun Lee
Seung Min Park
Jin Woong Suh
Jeong Yeon Kim
Jang Wook Sohn
Young Kyung Yoon
author_facet Yoon Hyun Sung
Yong Kuk Ju
Hak Jun Lee
Seung Min Park
Jin Woong Suh
Jeong Yeon Kim
Jang Wook Sohn
Young Kyung Yoon
author_sort Yoon Hyun Sung
collection DOAJ
description Abstract This study aimed to evaluate the usefulness of amplicon-based real-time metagenomic sequencing applied to cerebrospinal fluid (CSF) for identifying the causative agents of bacterial meningitis. We conducted a 16S rRNA amplicon sequencing using a nanopore-based platform, alongside routine polymerase chain reaction (PCR) testing or bacterial culture, to compare its clinical performance in pathogen detection on CSF samples. Among 17 patients, nanopore-based sequencing, multiplex PCR, and bacterial culture detected potential bacterial pathogens in 47.1%, 0%, and 47.1% samples, respectively. Nanopore-based sequencing demonstrated a sensitivity of 50.0%, specificity of 55.6%, positive predictive value of 50.0%, negative predictive value of 55.6%, and overall accuracy of 47.1%, compared to the gold standard method for bacterial culture. In 44.4% (4/9) of culture-negative cases, nanopore-based sequencing detected potentially causative pathogens, whereas four (23.5%) patients were positive only in culture. Using nanopore-based sequencing alongside bacterial culture increased the positivity rate from 47.1 to 70.6%. However, these values may be overestimated due to challenges in distinguishing significant pathogens from background noise. Meanwhile, the bioinformatics module in EPI2ME reduced the turn-around time to 10 min. Nanopore-based metagenomic sequencing is expected to serve as a complementary tool for pathogen detection in CSF samples by facilitating rapid and accurate diagnosis.
format Article
id doaj-art-b5a85fb3e0b447a2ac316a39cb1058e8
institution Kabale University
issn 2045-2322
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-b5a85fb3e0b447a2ac316a39cb1058e82025-02-02T12:21:54ZengNature PortfolioScientific Reports2045-23222025-01-0115111010.1038/s41598-025-87858-zClinical performance of real-time nanopore metagenomic sequencing for rapid identification of bacterial pathogens in cerebrospinal fluid: a pilot studyYoon Hyun Sung0Yong Kuk Ju1Hak Jun Lee2Seung Min Park3Jin Woong Suh4Jeong Yeon Kim5Jang Wook Sohn6Young Kyung Yoon7Institute of Emerging Infectious Diseases, Korea UniversityInstitute of Emerging Infectious Diseases, Korea UniversityInstitute of Emerging Infectious Diseases, Korea UniversityInstitute of Emerging Infectious Diseases, Korea UniversityDivision of Infectious Diseases, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of MedicineDivision of Infectious Diseases, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of MedicineInstitute of Emerging Infectious Diseases, Korea UniversityInstitute of Emerging Infectious Diseases, Korea UniversityAbstract This study aimed to evaluate the usefulness of amplicon-based real-time metagenomic sequencing applied to cerebrospinal fluid (CSF) for identifying the causative agents of bacterial meningitis. We conducted a 16S rRNA amplicon sequencing using a nanopore-based platform, alongside routine polymerase chain reaction (PCR) testing or bacterial culture, to compare its clinical performance in pathogen detection on CSF samples. Among 17 patients, nanopore-based sequencing, multiplex PCR, and bacterial culture detected potential bacterial pathogens in 47.1%, 0%, and 47.1% samples, respectively. Nanopore-based sequencing demonstrated a sensitivity of 50.0%, specificity of 55.6%, positive predictive value of 50.0%, negative predictive value of 55.6%, and overall accuracy of 47.1%, compared to the gold standard method for bacterial culture. In 44.4% (4/9) of culture-negative cases, nanopore-based sequencing detected potentially causative pathogens, whereas four (23.5%) patients were positive only in culture. Using nanopore-based sequencing alongside bacterial culture increased the positivity rate from 47.1 to 70.6%. However, these values may be overestimated due to challenges in distinguishing significant pathogens from background noise. Meanwhile, the bioinformatics module in EPI2ME reduced the turn-around time to 10 min. Nanopore-based metagenomic sequencing is expected to serve as a complementary tool for pathogen detection in CSF samples by facilitating rapid and accurate diagnosis.https://doi.org/10.1038/s41598-025-87858-zCerebrospinal fluidNanopore sequencingNext-generation sequencingMeningitisPoint-of-care testing
spellingShingle Yoon Hyun Sung
Yong Kuk Ju
Hak Jun Lee
Seung Min Park
Jin Woong Suh
Jeong Yeon Kim
Jang Wook Sohn
Young Kyung Yoon
Clinical performance of real-time nanopore metagenomic sequencing for rapid identification of bacterial pathogens in cerebrospinal fluid: a pilot study
Scientific Reports
Cerebrospinal fluid
Nanopore sequencing
Next-generation sequencing
Meningitis
Point-of-care testing
title Clinical performance of real-time nanopore metagenomic sequencing for rapid identification of bacterial pathogens in cerebrospinal fluid: a pilot study
title_full Clinical performance of real-time nanopore metagenomic sequencing for rapid identification of bacterial pathogens in cerebrospinal fluid: a pilot study
title_fullStr Clinical performance of real-time nanopore metagenomic sequencing for rapid identification of bacterial pathogens in cerebrospinal fluid: a pilot study
title_full_unstemmed Clinical performance of real-time nanopore metagenomic sequencing for rapid identification of bacterial pathogens in cerebrospinal fluid: a pilot study
title_short Clinical performance of real-time nanopore metagenomic sequencing for rapid identification of bacterial pathogens in cerebrospinal fluid: a pilot study
title_sort clinical performance of real time nanopore metagenomic sequencing for rapid identification of bacterial pathogens in cerebrospinal fluid a pilot study
topic Cerebrospinal fluid
Nanopore sequencing
Next-generation sequencing
Meningitis
Point-of-care testing
url https://doi.org/10.1038/s41598-025-87858-z
work_keys_str_mv AT yoonhyunsung clinicalperformanceofrealtimenanoporemetagenomicsequencingforrapididentificationofbacterialpathogensincerebrospinalfluidapilotstudy
AT yongkukju clinicalperformanceofrealtimenanoporemetagenomicsequencingforrapididentificationofbacterialpathogensincerebrospinalfluidapilotstudy
AT hakjunlee clinicalperformanceofrealtimenanoporemetagenomicsequencingforrapididentificationofbacterialpathogensincerebrospinalfluidapilotstudy
AT seungminpark clinicalperformanceofrealtimenanoporemetagenomicsequencingforrapididentificationofbacterialpathogensincerebrospinalfluidapilotstudy
AT jinwoongsuh clinicalperformanceofrealtimenanoporemetagenomicsequencingforrapididentificationofbacterialpathogensincerebrospinalfluidapilotstudy
AT jeongyeonkim clinicalperformanceofrealtimenanoporemetagenomicsequencingforrapididentificationofbacterialpathogensincerebrospinalfluidapilotstudy
AT jangwooksohn clinicalperformanceofrealtimenanoporemetagenomicsequencingforrapididentificationofbacterialpathogensincerebrospinalfluidapilotstudy
AT youngkyungyoon clinicalperformanceofrealtimenanoporemetagenomicsequencingforrapididentificationofbacterialpathogensincerebrospinalfluidapilotstudy